Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,198 | 189 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SUN PHARMACEUTICAL INDUSTRIES INC. | $775.56 | 54 | $0 (2024) |
| Allergan, Inc. | $723.74 | 22 | $0 (2022) |
| Bausch & Lomb Americas Inc. | $401.44 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $362.46 | 14 | $0 (2023) |
| ABBVIE INC. | $354.13 | 11 | $0 (2024) |
| Shire North American Group Inc | $290.56 | 15 | $0 (2019) |
| Oyster Point Pharma, Inc. | $169.16 | 7 | $0 (2024) |
| Mallinckrodt Enterprises LLC | $162.61 | 4 | $0 (2019) |
| Johnson & Johnson Vision Care, Inc. | $145.76 | 9 | $0 (2024) |
| Amgen Inc. | $138.45 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $966.80 | 48 | Bausch & Lomb Americas Inc. ($307.08) |
| 2023 | $757.09 | 41 | Sun Pharmaceutical Industries Inc. ($300.88) |
| 2022 | $520.04 | 22 | Sun Pharmaceutical Industries Inc. ($180.31) |
| 2021 | $247.53 | 15 | Allergan, Inc. ($76.18) |
| 2020 | $147.37 | 8 | Allergan, Inc. ($52.97) |
| 2019 | $509.67 | 19 | Novartis Pharmaceuticals Corporation ($175.22) |
| 2018 | $381.58 | 14 | Allergan Inc. ($152.09) |
| 2017 | $667.69 | 22 | Allergan Inc. ($337.97) |
All Payment Transactions
189 individual payment records from CMS Open Payments — Page 1 of 8
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $4.68 | General |
| Category: Ophthalmology | ||||||
| 12/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $89.45 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/10/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $4.07 | General |
| Category: Ophthalmology | ||||||
| 12/04/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $27.92 | General |
| Category: EYE CARE | ||||||
| 12/04/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $5.56 | General |
| Category: Ophthalmology | ||||||
| 11/27/2024 | Oyster Point Pharma, Inc. | RYZUMVI (Drug), TYRVAYA | Food and Beverage | In-kind items and services | $29.93 | General |
| Category: Pharmacologically-induced mydriasis | ||||||
| 11/27/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $25.45 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 11/27/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $19.72 | General |
| Category: Ophthalmology | ||||||
| 11/27/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $7.94 | General |
| Category: Ophthalmology | ||||||
| 11/18/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $27.24 | General |
| Category: Ophthalmology | ||||||
| 11/13/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $4.46 | General |
| Category: Ophthalmology | ||||||
| 11/08/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $6.75 | General |
| Category: Ophthalmology | ||||||
| 10/30/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug), XIIDRA | Food and Beverage | In-kind items and services | $124.99 | General |
| Category: Ophthalmology | ||||||
| 10/29/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $19.83 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 10/24/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $21.28 | General |
| Category: Ophthalmology | ||||||
| 10/22/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $3.67 | General |
| Category: Ophthalmology | ||||||
| 10/16/2024 | CooperVision Inc. | MyDay Contact Lens (Device) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Devices | ||||||
| 10/15/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $28.78 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/03/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $116.10 | General |
| Category: Ophthalmology | ||||||
| 10/02/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $6.39 | General |
| Category: Ophthalmology | ||||||
| 10/01/2024 | Johnson & Johnson Vision Care, Inc. | — | Food and Beverage | In-kind items and services | $18.23 | General |
| 10/01/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $17.39 | General |
| Category: Ophthalmology | ||||||
| 08/16/2024 | Bausch & Lomb Americas Inc. | VYZULTA (Drug), MIEBO | Food and Beverage | In-kind items and services | $4.71 | General |
| Category: Ophthalmology | ||||||
| 08/14/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.22 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/14/2024 | SUN PHARMACEUTICAL INDUSTRIES INC. | Cequa (Drug) | Food and Beverage | In-kind items and services | $8.37 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 31 | 32 | $5,280 | $2,077 |
| 2022 | 2 | 32 | 32 | $4,890 | $1,665 |
| 2021 | 3 | 51 | 59 | $8,520 | $3,492 |
| 2020 | 2 | 41 | 41 | $6,435 | $2,816 |
All Medicare Procedures & Services
9 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 19 | 19 | $3,135 | $1,142 | 36.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 12 | 13 | $2,145 | $935.15 | 43.6% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 19 | 19 | $3,135 | $1,410 | 45.0% |
| 92133 | Imaging of optic nerve | Office | 2022 | 13 | 13 | $1,755 | $254.76 | 14.5% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2021 | 27 | 28 | $4,620 | $2,104 | 45.5% |
| 92012 | Eye and medical examination for diagnosis and treatment, established patient | Office | 2021 | 12 | 19 | $2,280 | $1,099 | 48.2% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2021 | 12 | 12 | $1,620 | $289.40 | 17.9% |
| 92014 | Eye and medical examination for diagnosis and treatment, established patient, 1 or more visits | Office | 2020 | 30 | 30 | $4,950 | $2,554 | 51.6% |
| 92133 | Diagnostic imaging of optic nerve of eye | Office | 2020 | 11 | 11 | $1,485 | $262.66 | 17.7% |
About Dr. Heidi Gordon, O.D
Dr. Heidi Gordon, O.D is a Optometrist healthcare provider based in Lowell, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/16/2006. The National Provider Identifier (NPI) number assigned to this provider is 1144272618.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Heidi Gordon, O.D has received a total of $4,198 in payments from pharmaceutical and medical device companies, with $966.80 received in 2024. These payments were reported across 189 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($4,198).
As a Medicare-enrolled provider, Gordon has provided services to 155 Medicare beneficiaries, totaling 164 services with total Medicare billing of $10,051. Data is available for 4 years (2020–2023), covering 9 distinct procedure/service records.
Practice Information
- Specialty Optometrist
- Location Lowell, MI
- Active Since 05/16/2006
- Last Updated 07/08/2007
- Taxonomy Code 152W00000X
- Entity Type Individual
- NPI Number 1144272618
Products in Payments
- Cequa (Drug) $724.26
- XIIDRA (Drug) $691.94
- RESTASIS (Drug) $314.84
- LUMIGAN (Drug) $238.83
- VYZULTA (Drug) $219.21
- MIEBO (Drug) $211.29
- ACTHAR (Biological) $194.77
- VUITY (Drug) $173.11
- TYRVAYA (Drug) $139.23
- TEPEZZA (Biological) $138.45
- Acuvue (Device) $127.53
- MyDay Contact Lens (Device) $72.90
- TOTAL30 (Device) $61.29
- Prokera (Device) $50.85
- PROKERA (Device) $46.25
- XDEMVY (Drug) $45.28
- DURYSTA (Drug) $39.58
- rocklatan (Drug) $37.26
- rhopressa (Drug) $36.21
- INFUSE (Device) $33.70
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Optometrist Doctors in Lowell
Dr. Kevin Johnson, Od, OD
Optometrist — Payments: $5,602
Dr. Sarah Weeks, O.d, O.D
Optometrist — Payments: $4,142
Steven Sikalis, O.d, O.D
Optometrist — Payments: $3,681
Stephen Harney, O.d, O.D
Optometrist — Payments: $2,737
Jennifer Johnson, Od, OD
Optometrist — Payments: $2,584
Christopher Karalekas, O.d, O.D
Optometrist — Payments: $2,177